I-HCV(CMIA)

I-pathogenesis ye-hepatitis C ayikacaci.Xa i-HCV iphindaphinda kwiiseli zesibindi, ibangela utshintsho kwisakhiwo kunye nomsebenzi weeseli zesibindi okanye iphazamise ukuhlanganiswa kweeprotheni zeseli zesibindi, ezinokubangela ukuhla kunye necrosis yeeseli zesibindi, ebonisa ukuba i-HCV iyonakalisa ngokuthe ngqo isibindi kwaye idlala indima kwi-pathogenesis.Nangona kunjalo, uninzi lweemathematika lukholelwa ukuba i-cellular immunopathological reaction inokudlala indima ebalulekileyo.Bafumanise ukuba i-hepatitis C, njenge-Hepatitis B, ine-CD3+engena iiseli ikakhulu kwizihlunu zayo.Iiseli ze-Cytotoxic T (TC) zihlasela ngokuthe ngqo iiseli ezijoliswe kuzo zosulelo lwe-HCV, ezinokubangela umonakalo weseli yesibindi.


Iinkcukacha zeMveliso

Iithegi zeMveliso

Ulwazi olusisiseko

Igama lemveliso Ikhathalogu Uhlobo Umamkeli/uMthombo Ukusetyenziswa Usetyenziso I-Epitope I-COA
I-HCV Core-NS3-NS5 i-antigen ye-fusion I-BMIHCV203 I-Antigen E.coli Bamba CMIA,
WB
/ Khuphela
I-HCV Core-NS3-NS5 i-antigen ye-fusion I-BMIHCV204 I-Antigen E.coli Hlanganisa CMIA,
WB
/ Khuphela
I-HCV Core-NS3-NS5 fusion antigen-Bio BMIHCVB02 I-Antigen E.coli Hlanganisa CMIA,
WB
/ Khuphela
I-HCV Core-NS3-NS5 i-antigen ye-fusion I-BMIHCV213 I-Antigen HEK293 Iseli Hlanganisa CMIA,
WB
/ Khuphela

I-pathogenesis ye-hepatitis C ayikacaci.Xa i-HCV iphindaphinda kwiiseli zesibindi, ibangela utshintsho kwisakhiwo kunye nomsebenzi weeseli zesibindi okanye iphazamise ukuhlanganiswa kweeprotheni zeseli zesibindi, ezinokubangela ukuhla kunye necrosis yeeseli zesibindi, ebonisa ukuba i-HCV iyonakalisa ngokuthe ngqo isibindi kwaye idlala indima kwi-pathogenesis.Nangona kunjalo, uninzi lweemathematika lukholelwa ukuba i-cellular immunopathological reaction inokudlala indima ebalulekileyo.Bafumanise ukuba i-hepatitis C, njenge-Hepatitis B, ine-CD3+engena iiseli ikakhulu kwizihlunu zayo.Iiseli ze-Cytotoxic T (TC) zihlasela ngokuthe ngqo iiseli ezijoliswe kuzo zosulelo lwe-HCV, ezinokubangela umonakalo weseli yesibindi.

I-RIA okanye i-ELISA

I-Radioimmunodiagnosis (RIA) okanye i-enzyme-linked immunosorbent assay (ELISA) yayisetyenziselwa ukufumanisa i-anti HCV kwi-serum.Ngowe-1989, uKuo et al.waseka indlela radioimmunoassay (RIA) for anti-C-100.Kamva, iNkampani ye-Ortho iphuhlise ngempumelelo i-enzyme-linked immunosorbent assay (ELISA) ukuze ibone i-anti-C-100.Zombini iindlela zisebenzisa igwele recombinant ibonakaliswe virus antigen (C-100-3, iproteni encoded yi NS4, equlathe 363 amino acids), emva kokucocwa, iqatywe ngenani elincinane imingxunya ipleyiti yeplastiki, kwaye yongezwa kunye neserum evavanyiweyo.I-antigen yentsholongwane idityaniswa ne-anti-C-100 kwi-serum evavanyiweyo.Okokugqibela, isotope okanye i-enzyme ebhalwe imouse anti human lgG monoclonal antibody iyongezwa, kwaye i-substrate yongezwa ukuzimisela kombala.


  • Ngaphambili:
  • Okulandelayo:

  • Shiya uMyalezo Wakho